Stocky turns companies like CHYM into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Cautious. Chyme's modest 49.6 Growth Compounder Score reflects uneven expansion, while a 40.9× forward P/E and 18/100 Value score signal premium pricing with limited margin of safety. Leadership alignment (55/100) lacks clear founder-CEO ownership or capped dilution signals. Medium-severity dependencies on banking partners (The Bancorp, Stride) and card networks for interchange revenue create structural vulnerability without offsetting competitive moats.
Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for CHYM:
Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 42/100, you know instantly whether to dig deeper or skip.
Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.
Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.
Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.
Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.
Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.
Stocky rates CHYM (CHYM) at 42/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. Chyme's modest 49.6 Growth Compounder Score reflects uneven expansion, while a 40.9× forward P/E and 18/100 Value score signal premium pricing with limited margin of safety. Leadership alignment (55/100) lacks clear founder-CE
CHYM's current Stocky Verdict is 42/100, placing it in the "Cautious" band. This composite combines a 50/100 Compounder score, 55/100 Leadership, Moat rating, and analyst signal.
Stocky hasn't finalised a Moat Score for CHYM yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.
CHYM scores 55/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.
CHYM's Vulnerability Profile scores 25/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to CHYM.
Sign up free and unlock the full analysis on CHYM — the same tools professional analysts use, personalised to your portfolio:
Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.
This page is just a preview. Open the live, interactive version for the full picture:
Or jump straight to the interactive dashboard for CHYM in the app.
